Lexington, MA, United States of America

Howard Benjamin

USPTO Granted Patents = 7 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 334(Granted Patents)


Company Filing History:


Years Active: 1998-2010

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovation and Impact: The Contributions of Howard Benjamin

Introduction: Howard Benjamin, an accomplished inventor based in Lexington, MA, has made significant contributions to the field of biotechnology, holding a total of 7 patents. His work primarily focuses on modulating amyloid aggregation, which plays a critical role in various neurodegenerative diseases.

Latest Patents: Howard's most recent patents highlight his innovative approach to tackling amyloidogenic diseases. One such patent involves "Modulators of amyloid aggregation,” which encompasses compounds designed to either promote or inhibit the aggregation of amyloidogenic proteins or peptides. His invention particularly emphasizes compounds that can modulate the aggregation of natural β-amyloid peptides (β-AP), aiming to alter or hinder neurotoxicity in these proteins. Additionally, he has developed anchor libraries to identify peptide binding sequences, enabling advancements in understanding how specific peptides interact with target proteins.

Career Highlights: Howard Benjamin has achieved recognition in the biotechnology sector through his tenure at Praecis Pharmaceuticals, Inc., where he has worked diligently on the forefront of scientific discovery. His patents facilitate the development of diagnostic tools and therapeutic methods for treating amyloid-related conditions, showcasing his commitment to improving healthcare outcomes.

Collaborations: Throughout his career, Howard has collaborated with notable individuals, including Malcolm L Gefter and Ethan R Signer, which has fostered a culture of innovation and excellence within his research endeavors. These collaborations have resulted in a collective effort to address pressing health challenges associated with amyloid aggregation.

Conclusion: Howard Benjamin's innovative spirit and dedication to scientific progress underscore his role as a pivotal figure in the biotechnology landscape. His patents, particularly in the realm of amyloid aggregation modulation, not only demonstrate his creativity as an inventor but also contribute significantly to the ongoing fight against neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…